Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Arcturus Therapeutics, Inc.

Clinical trials sponsored by Arcturus Therapeutics, Inc., explained in plain language.

Arcturus Therapeutics, Inc. ARCT NASDAQ

RNA medicines company developing mRNA-based therapies and vaccines.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 4 Terminated 1

New mRNA drug hopes to help cystic fibrosis patients who Can't use current therapies

Disease control Recruiting now

This study tests an experimental mRNA medicine called ARCT-032 in 33 adults with cystic fibrosis who cannot take or do not benefit from current CFTR modulators. The goal is to see if the drug is safe and can improve lung function and quality of life. Participants will receive mul…

Phase: PHASE2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC